AlphaYouENGN: Grossman William discloses a purchase
By AlphaYouPublished Form 4
Grossman William
Reporting filer
Grossman William reported Purchase in enGene Therapeutics Inc.: 5102 units of Common Shares, dated 2026-09-22. The full Form 4 contains 1 transaction entry.
- Disclosed
- Sep 24, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Shares | Grossman William | 2026-09-22 | P | Purchase | 5102 | 1.97 | 5,102 | 2 days | Filed terms
|
Common Shares
- Owner
- Grossman William
- Date
- 2026-09-22
- Code
- P
- Action
- Purchase
- Quantity
- 5102
- Price
- 1.97
- Following holdings
- 5,102
- Reporting delay
- 2 days
- Filed terms and references
Filed terms
- security Title: Common Shares
- transaction Date: 2026-09-22
- deemed Execution Date:
- transaction Form Type: 4
- transaction Code: P
- equity Swap Involved: 0
- transaction Timeliness:
- transaction Shares: 5102
- transaction Price Per Share: 1.97
- transaction Acquired Disposed Code: A
- shares Owned Following Transaction: 5102
- direct Or Indirect Ownership: D
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Grossman William: Interim Chief Medical Officer, Director.
Original sources
Prepared automatically from public filing data. Report a correction.